APA (7th ed.) Citation

Salviano-Silva, A., Maire, C., Wollmann, K., Reimer, R., Neumann, J., Dottermusch, M., . . . Ricklefs, F. L. (2023). BIOM-32. EVS CARRYING TENASCIN-C ENABLE TUMOR-SPECIFIC MUTATION ANALYSIS IN GLIOBLASTOMA PATIENTS. Neuro-oncology (Charlottesville, Va.), 25(Supplement_5), v11. https://doi.org/10.1093/neuonc/noad179.0043

Chicago Style (17th ed.) Citation

Salviano-Silva, Amanda, et al. "BIOM-32. EVS CARRYING TENASCIN-C ENABLE TUMOR-SPECIFIC MUTATION ANALYSIS IN GLIOBLASTOMA PATIENTS." Neuro-oncology (Charlottesville, Va.) 25, no. Supplement_5 (2023): v11. https://doi.org/10.1093/neuonc/noad179.0043.

MLA (9th ed.) Citation

Salviano-Silva, Amanda, et al. "BIOM-32. EVS CARRYING TENASCIN-C ENABLE TUMOR-SPECIFIC MUTATION ANALYSIS IN GLIOBLASTOMA PATIENTS." Neuro-oncology (Charlottesville, Va.), vol. 25, no. Supplement_5, 2023, p. v11, https://doi.org/10.1093/neuonc/noad179.0043.